How amantadine and rimantadine inhibit proton transport in the M2 protein channel.
暂无分享,去创建一个
Thanyada Rungrotmongkol | Supot Hannongbua | Maturos Malaisree | Panita Decha | Pornthep Sompornpisut | Somsak Pianwanit | Ornjira Aruksakunwong | Pathumwadee Intharathep | Chittima Laohpongspaisan | T. Rungrotmongkol | S. Hannongbua | M. Malaisree | P. Decha | Pathumwadee Intharathep | P. Sompornpisut | Arthorn Loisruangsin | Krit Chuenpennit | Nopphorn Kaiyawet | Nopphorn Kaiyawet | A. Loisruangsin | Ornjira Aruksakunwong | Chittima Laohpongspaisan | S. Pianwanit | Krit Chuenpennit | Somsak Pianwanit
[1] M. Sansom,et al. Influenza virus M2 protein: a molecular modelling study of the ion channel. , 1993, Protein engineering.
[2] D. M. F. Aalten,et al. PRODRG, a program for generating molecular topologies and unique molecular descriptors from coordinates of small molecules , 1996, J. Comput. Aided Mol. Des..
[3] G. Veglia,et al. Dipolar waves as NMR maps of protein structure. , 2002, Journal of the American Chemical Society.
[4] R. Reichman,et al. A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection. , 1982, The New England journal of medicine.
[5] Gregory A Voth,et al. Proton transport behavior through the influenza A M2 channel: insights from molecular simulation. , 2007, Biophysical journal.
[6] N. Cox,et al. Global epidemiology of influenza: past and present. , 2000, Annual review of medicine.
[7] R. Lamb,et al. A functionally defined model for the M2 proton channel of influenza A virus suggests a mechanism for its ion selectivity. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[8] R. Broadhurst,et al. Interaction between an amantadine analogue and the transmembrane portion of the influenza A M2 protein in liposomes probed by 1H NMR spectroscopy of the ligand. , 2004, Journal of medicinal chemistry.
[9] A. Hay,et al. Structural characteristics of the M2 protein of influenza a viruses: Evidence that it forms a tetrameric channe , 1991, Virology.
[10] H. Berendsen,et al. A consistent empirical potential for water–protein interactions , 1984 .
[11] H. Takeuchi,et al. Protonation of histidine and histidine-tryptophan interaction in the activation of the M2 ion channel from influenza a virus. , 2001, Biochemistry.
[12] R. Ashley,et al. The transmembrane domain of influenza A M2 protein forms amantadine-sensitive proton channels in planar lipid bilayers. , 1992, Virology.
[13] R. Lamb,et al. Cu(II) Inhibition of the Proton Translocation Machinery of the Influenza A Virus M2 Protein* , 1999, The Journal of Biological Chemistry.
[14] G. R. Smith,et al. The influenza A virus M2 channel: a molecular modeling and simulation study. , 1997, Virology.
[15] R. Lamb,et al. Ion channel activity of influenza A virus M2 protein: characterization of the amantadine block , 1993, Journal of virology.
[16] Berk Hess,et al. LINCS: A linear constraint solver for molecular simulations , 1997 .
[17] A. Hay,et al. Differences in conductance of M2 proton channels of two influenza viruses at low and high pH , 2003, The Journal of physiology.
[18] H. Berendsen,et al. Molecular dynamics with coupling to an external bath , 1984 .
[19] P. Adams,et al. Experimentally based orientational refinement of membrane protein models: A structure for the Influenza A M2 H+ channel. , 1999, Journal of molecular biology.
[20] J Wang,et al. Structure of the transmembrane region of the M2 protein H+ channel , 2001, Protein science : a publication of the Protein Society.
[21] J. Oxford,et al. Antiviral activity of amantadine: a review of laboratory and clinical data. , 1980, Pharmacology & therapeutics.
[22] R. Lamb,et al. Influenza virus M2 integral membrane protein is a homotetramer stabilized by formation of disulfide bonds. , 1991, Virology.
[23] D. Tieleman,et al. Defining the transmembrane helix of M2 protein from influenza A by molecular dynamics simulations in a lipid bilayer. , 1999, Biophysical journal.
[24] R. Lamb,et al. Initial structural and dynamic characterization of the M2 protein transmembrane and amphipathic helices in lipid bilayers , 2003, Protein science : a publication of the Protein Society.
[25] R. Lamb,et al. Permeation and Activation of the M2 Ion Channel of Influenza A Virus* , 2000, The Journal of Biological Chemistry.
[26] Huan‐Xiang Zhou,et al. Histidines, heart of the hydrogen ion channel from influenza A virus: toward an understanding of conductance and proton selectivity. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[27] T. Hien,et al. Avian influenza A (H5N1) , 2005, Journal of Clinical Virology.
[28] J. Englund. Antiviral therapy of influenza. , 2002, Seminars in pediatric infectious diseases.
[29] David S. Goodsell,et al. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function , 1998 .
[30] I. Arkin,et al. How pH opens a H+ channel: the gating mechanism of influenza A M2. , 2005, Structure.
[31] R. Bertram,et al. Backbone structure of the amantadine-blocked trans-membrane domain M2 proton channel from Influenza A virus. , 2007, Biophysical journal.
[32] R. Lamb,et al. Activation of the M2 ion channel of influenza virus: a role for the transmembrane domain histidine residue. , 1995, Biophysical journal.
[33] T. Darden,et al. Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems , 1993 .
[34] R. Lamb,et al. Influenza virus M2 protein is an integral membrane protein expressed on the infected-cell surface , 1985, Cell.
[35] Lawrence H. Pinto,et al. Influenza virus M2 protein has ion channel activity , 1992, Cell.
[36] D. Tieleman,et al. Exploring models of the influenza A M2 channel: MD simulations in a phospholipid bilayer. , 2000, Biophysical journal.
[37] Sanguk Kim,et al. The closed state of a H+ channel helical bundle combining precise orientational and distance restraints from solid state NMR. , 2002, Biochemistry.
[38] A. Hay,et al. Selective proton permeability and pH regulation of the influenza virus M2 channel expressed in mouse erythroleukaemia cells. , 1996, The Journal of physiology.
[39] Berk Hess,et al. GROMACS 3.0: a package for molecular simulation and trajectory analysis , 2001 .
[40] R. Webster,et al. H5N1 influenza--continuing evolution and spread. , 2006, The New England journal of medicine.
[41] R. Lamb,et al. The active oligomeric state of the minimalistic influenza virus M2 ion channel is a tetramer. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[42] M. Miles,et al. The Anti-Influenza Virus Drug Rimantadine Has Trypanocidal Activity , 1999, Antimicrobial Agents and Chemotherapy.
[43] J. Skehel,et al. The molecular basis of the specific anti‐influenza action of amantadine. , 1985, The EMBO journal.
[44] J. Taubenberger,et al. The origin of the 1918 pandemic influenza virus: a continuing enigma. , 2003, The Journal of general virology.
[45] J. Bradshaw,et al. Neutron diffraction reveals the site of amantadine blockade in the influenza A M2 ion channel. , 1994, Virology.
[46] R. Lamb,et al. Controlling influenza virus replication by inhibiting its proton channel. , 2007, Molecular bioSystems.